Image

Effect of HIIT on Post-Stroke Fatigue

Effect of HIIT on Post-Stroke Fatigue

Recruiting
40-80 years
All
Phase N/A

Powered by AI

Overview

This study aims to investigate the effect of high-intensity interval training (HIIT) on fatigue severity among individuals with chronic stroke. Participants will be randomly assigned to the HIIT group, the moderate-intensity continuous training (MICT) group, or the stretching group (active control). Each group will participate in supervised exercise sessions three times per week over a 12-week period, totaling 36 sessions. Outcome assessments will be conducted at baseline, mid-intervention (week 6), post-intervention (week 12), and follow-up (week 20). The primary outcome will be fatigue severity. Secondary outcomes will include inflammatory biomarkers and additional health-related indicators.

Eligibility

Inclusion criteria:

  • Age of 40-80 years;
  • a history of ischemic stroke resulting in unilateral limb impairment 6-60 months prior to consent to participate in the pilot trial;
  • a stable medical condition;
  • a subjective feeling of fatigue, defined as a period of apparent fatigue, decreased energy, increased need for rest, or fatigue out of proportion to physical activity for at least 2 weeks during the past month;
  • ability to communicate with the investigators and lack of significant cognitive deficits;
  • able to walk for 10 meters with or without a walking aid.

Exclusion criteria:

  • An FSS score of \< 4 (20);
  • other neurological conditions;
  • other musculoskeletal comorbidities that would prevent safe participation in exercises;
  • a medical diagnosis of significant cardiovascular, pulmonary, or metabolic disease(s);
  • signs or symptoms indicative of significant cardiovascular, pulmonary, or metabolic disease(s) during the previous 3 months;
  • severe lower limb spasticity (Ashworth Scale score ≥ 3);
  • Botulinum toxin use in the affected lower limb within the past six months;
  • current or previous use of drugs intended to resolve post-stroke fatigue;
  • active engagement in other stroke rehabilitation trials.

Study details
    Stroke

NCT07273058

The Hong Kong Polytechnic University

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.